The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United ... contending that the FTC has ...

I'm an antitrust expert and former FTC general counsel ... largely by increasing management costs. Due to changes in the incidence of PBM services over the drug life cycle, the services encourage ...

The Federal Trade Commission (FTC) recently sued the three largest pharmacy benefit managers (PBMs ... engage in treatment involving expensive drug products. The complaint argues that the ...

largest pharmacy benefit managers for their alleged role ... fact-based assessment of PBMs or the prescription drug market,” contending that the FTC “completely overlooks the volumes of ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

FTC accuses CVS, Cigna, and UnitedHealth of driving up insulin prices through rebates. PBMs administer 80% of U.S. prescriptions and allegedly inflate life-saving insulin costs. The complaint ...

CVS Health, Cigna and UnitedHealth Group are demanding that FTC Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the company and other drug middlemen of ...

The Federal Trade Commission’s study of pharmacy benefit managers’ effect on the prescription-drug market is one of ... who is often critical of the FTC. On this point, however, we are ...

CVS Health Corp. and UnitedHealth Group Inc. said members of the US Federal Trade Commission who voted to sue prescription ... by the FTC commissioners criticizing pharmacy benefit managers ...